Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Drugs Dermatol ; 11(11): e66-9, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23135096

RESUMO

BACKGROUND: Common warts caused by the human papillomavirus (HPV) are considered to be the most common infectious skin disease. No individual treatment for common warts is effective as monotherapy in eradicating the lesions. The aim of this study is to evaluate the clinical efficacy of a 35% and an 80% trichloroacetic acid (TCA) solution in the treatment of the common wart. METHODS: In this single-blinded clinical trial, 62 eligible patients with common warts referred to the dermatology clinic of Ghaem Hospital in Mashhad, Iran. Patients were randomly divided into two groups, each treated with a TCA solution (group A, TCA 80%; group B, TCA 35%) once per week until complete clearance of the lesions or for a maximum duration of six weeks. Seven patients were excluded from the final analysis (one patient in group A and six patients in group B) for various reasons, including irregular follow-up, using physical tools such as razor blades to remove the lesion, and failure to complete treatment; and 55 patients were included in the final analysis. RESULTS: Improvement to treatment responses was classified as: no change (no changes in the number of warts), mild (clearing of less than 25% of warts), moderate (clearing of 25% to 75% of warts), and good (clearing of more than 75% of warts). At the end of follow-up, the clinical improvement of group A (n=30) was: 10 patients (33.3%) with a mild response, 6 patients (20%) with a moderate response, and 14 patients (46.7%) with a good response. In group B (n=25), 16 patients (64%) showed a mild response, 6 patients (24%) a moderate response, and 3 patients (12%) a good response. There was a statistically significant difference in improvement between the two treatment groups (P=.017). Improvement was greater with a higher concentration of TCA solution. CONCLUSION: This study showed that a different concentration of TCA solution was an effective form of treatment for common warts. Trichloroacetic acid 80% is more effective, but this solution must be used only with careful consideration by a physician.


Assuntos
Cáusticos/uso terapêutico , Infecções por Papillomavirus/tratamento farmacológico , Ácido Tricloroacético/uso terapêutico , Verrugas/tratamento farmacológico , Administração Cutânea , Adolescente , Adulto , Cáusticos/administração & dosagem , Criança , Relação Dose-Resposta a Droga , Feminino , Seguimentos , Humanos , Masculino , Infecções por Papillomavirus/virologia , Método Simples-Cego , Resultado do Tratamento , Ácido Tricloroacético/administração & dosagem , Verrugas/virologia , Adulto Jovem
2.
Artigo em Inglês | MEDLINE | ID: mdl-20043056

RESUMO

A seventeen-year-old male presented with a restriction in the oral cavity. The oral mucosa was white and he could not protrude his tongue. For 4 years he had habitually held a powdery material containing betel nut in the oral vestibule for several minutes a day. A biopsy of the labial mucosa was carried out and a diagnosis of oral submucous fibrosis was confirmed. This is a premalignant condition. Oral submucous fibrosis is very rare in young patients.


Assuntos
Fibrose Oral Submucosa/patologia , Adolescente , Areca , Humanos , Masculino , Mucosa Bucal/patologia , Fibrose Oral Submucosa/etiologia
3.
Am J Trop Med Hyg ; 77(1): 99-101, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17620637

RESUMO

Cutaneous leishmaniasis (CL) treatment is painful, and cosmetic results are often unsatisfying. Azithromycin has been reported to be effective in treatment of CL caused by Leishmania viannia braziliensis. The efficacy of azithromycin was compared with Glucantime in treatment of Old World leishmaniasis. Of 49 patients, 22 received 500 mg/day azithromycin for 5 days/month. Treatment cycles were repeated monthly to a maximum of 4 months; 27 patients received 60 mg/kg intramuscular meglumine antimoniate for 20 days. Both groups were followed up for 16 weeks. In the azithromycin group, 2 patients withdrew because of GI symptoms. The response rates of 20 patients (29 lesions) were as follows: full improvement, 10.3%; partial improvement, 27.6%; and 62.1%, no response. In the glucantime group with 27 patients (58 lesions), these rates were 34.4%, 13.8%, and 51.7%, respectively (P = 0.036). Azithromycin was determined to be not as effective as Glucantime in treatment of Old World CL.


Assuntos
Antiprotozoários/uso terapêutico , Azitromicina/uso terapêutico , Leishmaniose Cutânea/tratamento farmacológico , Administração Oral , Adulto , Antiprotozoários/administração & dosagem , Azitromicina/administração & dosagem , Feminino , Humanos , Injeções Intramusculares , Leishmaniose Cutânea/patologia , Masculino , Meglumina/administração & dosagem , Meglumina/uso terapêutico , Antimoniato de Meglumina , Compostos Organometálicos/administração & dosagem , Compostos Organometálicos/uso terapêutico , Estudos Prospectivos , Índice de Gravidade de Doença , Resultado do Tratamento
4.
J Cutan Med Surg ; 19(2): 140-3, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25775635

RESUMO

BACKGROUND: Although the occurrence of psoriasis and vitiligo is reported in a few studies, no proper relationship has been found between these two diseases. OBJECTIVE: The aim of this study was to identify the frequency of the coincidence of these two diseases. METHOD: A descriptive and cross-sectional study was conducted on 6,200 patients referred to dermatology clinics from September 2004 to June 2005. RESULTS: Among these patients, 219 and 154 patients suffered from psoriasis (3.53%) and vitiligo (2.48%), respectively, and 12 patients (0.19%) had psoriasis and vitiligo simultaneously. The coincidence in the psoriasis group was 5.48% and in the vitiligo group was 7.79%, so the coincidence of both diseases was greater than the incidence of each alone. This association was significant (p = .004). CONCLUSION: Coincidence of these two diseases was seen, but more studies should be done to find common genetic and immunologic factors.


Assuntos
Psoríase/epidemiologia , Vitiligo/epidemiologia , Adulto , Comorbidade , Estudos Transversais , Feminino , Humanos , Irã (Geográfico)/epidemiologia , Masculino , Prevalência , Estudos Retrospectivos , Fatores de Risco
5.
Iran J Basic Med Sci ; 16(3): 281-3, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24470878

RESUMO

OBJECTIVE(S): One of the different types of skin leishmaniasis is the Chronic Lupoid Leishmaniasis (CLL), which is caused by abnormal immune response. On the other hand, HTLV-I has been known to exist in some infectious diseases. Human T cell lymphotropic virus type1 (HTLV-I) and cutanous leishmaniasis exists endemically in Mashhad. The objective of this study was to evaluate the prevalence of HTLV-I in CLL patients. MATERIALS AND METHODS: This cross sectional study involved 51 CLL patients admitted to cutaneous leishmaniasis clinics of Ghaem and Imam Reza hospitals in Mashhad, Iran. The blood samples were examined for serology tests through ELISA method. RESULTS: The results of the experiments for evaluating the existence of HTLV-I in 51 patients under study in this research were proved to be negative. CONCLUSION: According to this pilot study, the distribution of HTLV-I in CLL patients is not higher than normal population.

6.
Iran J Basic Med Sci ; 15(3): 840-4, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-23493098

RESUMO

OBJECTIVES: Human papillomavirus (HPV) infections are related to the genesis of various benign lesions and some malignant tumors, but no clear relationship has been identified so far between the subtypes of HPV and skin tag. MATERIALS AND METHODS: The present case-control study was designed to detect the existence of low risk and high risk HPV types in lesions of 50 patients with skin tag (case group) and normal skin around the melanocytic nevus of 30 patients (control group), using PCR. RESULTS: All of the samples were negative for HPV subtypes, except two samples in control group which were positive for high risk HPV. There was no significant relationship between the HPV subtypes and skin tag. CONCLUSION: There is no association between skin tag and low risk and high risk human papillomaviruses.

7.
Iran J Allergy Asthma Immunol ; 11(3): 236-40, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22947909

RESUMO

Chronic idiopathic urticaria is defined as recurrent hives occurring for at least 6 weeks. In the majority of cases, there is no identifiable underlying etiology despite extensive evaluation. A subset of these patients is classified as having autoimmune urticaria defined by the presence of a functional IgG antibody to the α subunit of the high-affinity IgE receptor (FceRIa) or to IgE. The aim of this study was to evaluate the effects of the drug atorvastatin in patients with chronic urticaria compared to the placebo.In this single-blind study, 50 patients suffering from chronic urticaria (15-45 years old) were selected and divided into two groups by simple randomization method. The first group was treated with atorvastatin and antihistamines and the second group (control group) was treated with placebo and antihistamines for 3 months. Urticaria severity was measured by score index, before and after the treatment course: ASST (autologous serum skin test) was performed for all patients and sera were collected to measure cytokines. In cases, IL-5 decreased and IL-10 increased after treatment compared to the time point before treatment (p<0.05). All patients with severe utricaria according our scoring, had positive ASST.The patients with severe urticaria identified by urticaria score and ASST positivity had chronic idiopathic urticaria. By prescribing the atorvastatin plus antihistamines in severe and resistant forms of urticaria, the use of more toxic medications like cytotoxic drugs may be avoided.


Assuntos
Ácidos Heptanoicos/uso terapêutico , Antagonistas dos Receptores Histamínicos/uso terapêutico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Pirróis/uso terapêutico , Urticária/tratamento farmacológico , Adolescente , Adulto , Atorvastatina , Biomarcadores/sangue , Doença Crônica , Citocinas/sangue , Quimioterapia Combinada , Feminino , Humanos , Mediadores da Inflamação/sangue , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Método Simples-Cego , Fatores de Tempo , Resultado do Tratamento , Urticária/sangue , Urticária/diagnóstico , Urticária/imunologia , Adulto Jovem
8.
Dermatol Res Pract ; 2011: 269515, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21747837

RESUMO

The purpose of this study was to investigate comparison between oral zinc sulfate and meglumine antimoniate in the treatment of cutaneous leishmaniasis (CL). So 100 patients with CL were included and randomly divided into two groups. The first group was treated with oral zinc sulfate (10 mg/kg/day during 45 days period), and the second group was treated with systemic meglumine antimoniate (20 mg/kg/day intramuscularly for 20 days). Acceptable cure after completing 45 days of followup occurred in 30.2% of lesions in first group, while this was 35.5% for the second group. There is not any significant difference between the two treatment groups (P = 0.42). Serious side effects resulting in treatment discounting occurred in only meglumine antimoniate group. Although cure rate of systemic meglumine antimoniate group was better the treatment with zinc sulfate is much easier, cheaper, more convenient in consumption, safer, and nearly close cure percentage to systemic meglumine antimoniate injections without serious side effect.

9.
Int J Dermatol ; 50(11): 1343-1346, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22004485

RESUMO

BACKGROUND: The role of nutritional factors including trace elements has been reported in the pathogenesis of many autoimmune diseases. OBJECTIVE: Regarding the relatively high prevalence of pemphigus vulgaris in Iran, we investigated the serum levels of zinc and copper as two important trace elements, together with the oxidative stress status in patients with pemphigus vulgaris. MATERIALS AND METHODS: This case-control study was performed on 25 patients with newly diagnosed pemphigus vulgaris and 25 age- and sex-matched healthy control subjects. Serum concentrations of zinc, copper, ceruloplasmin as well as copper/zinc ratio were determined for each subject. Oxidative stress was also measured using a novel assay of peroxidant-antioxidant balance (PAB). RESULTS: Mean serum concentrations of zinc and copper as well as copper/zinc ratio were significantly lower in patients (mean age: 47.2±16.2 years; male/female: 14/11) compared with the controls (mean age: 47.3±12.8 years; male/female: 14/11; P<0.001). In contrast, PAB values were significantly elevated in patients compared with controls (P<0.01). No significant difference in serum ceruloplasmin concentrations was observed between the groups (P>0.05). CONCLUSION: Our findings indicate that low serum zinc and copper and increased oxidative stress may be associated with pemphigus vulgaris.


Assuntos
Cobre/sangue , Estresse Oxidativo , Pênfigo/sangue , Zinco/sangue , Adulto , Estudos de Casos e Controles , Ceruloplasmina/metabolismo , Cobre/deficiência , Feminino , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Zinco/deficiência
10.
Am J Trop Med Hyg ; 80(2): 172-5, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19190206

RESUMO

We compared intralesional glucantine and cryotherapy for treatment of children with cutaneous leishmaniasis in Iran. We observed that cryotherapy is an effective treatment for cutaneous leishmaniasis in children. No serious post-treatment side effects were observed in either group. At six months of follow-up, no recurrence of disease was observed in cured patients in either group. Because of its simplicity, lower cost, low rate of serious complications, and greater tolerability, cryotherapy should be recommended as an appropriate alternative treatment for leishmaniasis in children.


Assuntos
Antiprotozoários/uso terapêutico , Crioterapia , Leishmaniose Cutânea/tratamento farmacológico , Leishmaniose Cutânea/terapia , Meglumina/uso terapêutico , Compostos Organometálicos/uso terapêutico , Criança , Pré-Escolar , Feminino , Humanos , Injeções Intralesionais , Irã (Geográfico) , Leishmaniose Cutânea/parasitologia , Masculino , Antimoniato de Meglumina , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa